Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2026.

Date: 11.08.2026 BSE Limited The Compliance Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 531592 Subject: Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2026. Ref.: Regulations 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/ Madam, Pursuant to Regulations 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Circular No. CIR/CFD/CMDI/162/2019 dated December 24, 2019; we hereby confirm that there is no deviation or variation in the use of proceeds, from the objects stated in the Letter of Offer for Rights Issue of the Company. A statement of deviation, stating that there is no deviation or variation in the utilization of these proceeds, duly reviewed by the Audit Committee, is attached herewith. Kindly take the same on records for your perusal. Thanking you, Yours faithfully, For Genpharmasec Limited Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728 Encl:- As Above Deviation/Variation in utilization of funds raised Name of listed entity Genpharmasec Ltd. Mode of Fund Raising Rights Issues Date of Raising Funds 21st February, 2024 (Date of Allotment) Amount Raised (Rs. In Lakhs) Rs. 4,845.05 Report filed for Quarter ended June 30, 2026 Monitoring Agency Not Applicable Monitoring Agency Name, if applicable ---- Is there a Deviation / Variation in use of funds raised No If yes, whether the same is pursuant to change in terms Not Applicable of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval Not Applicable Explanation for the Deviation / Variation Not Applicable Comments of the Audit Committee after review No Comments Comments of the auditors, if any No Comments Objects for which funds have been raised and where there has been a deviation, in the following table (Rs. In Lakhs) Original Object Modified Original Modificatio, Funds Amount of Rema Object, if Allocation Allocation, Utilised Deviation/ rks if any if any Variation for any the quarter according to applicable object To acquire Equity Shares from Not Rs. 1443.58 Not Rs. 1443.58 NIL - existing shareholders of Applicable Applicable Derren Healthcare Private Limited and making it subsidiary Company. To repay or prepay, in Full or Not Rs. 588.00 Not Rs. 289.00 NIL - in part, of certain Borrowings Applicable Applicable availed by our Company. To part finance the working Not Rs. 1650.00 Not Rs. 1650.00 NIL - capital of the Company. Applicable Applicable To Meet General corporate Not Rs. 1138.47 Not Rs. 1138.47 NIL - purposes. Applicable Applicable To meet the expenses of the Not Rs. 25.00 Not Rs. 25.00 NIL - Issue. Applicable Applicable Deviation or variation could mean: a) Deviation in the objects or purposes for which the funds have been raised or b) Deviation in the amount of funds actually utilized as against what was originally disclosed or c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. For Genpharmasec Limited Mr. Sohan Chaturvedi Whole time director & CFO DIN- 09629728